SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-16-052419
Filing Date
2016-02-16
Accepted
2016-02-12 17:41:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SANDS CAPITAL MANAGEMENT SC13GA 12-31-2015 (BIOMARIN PHARMACEUTICAL INC) bmrn0216.txt SC 13G/A 6221
  Complete submission text file 0001140361-16-052419.txt   8065
Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1101 WILSON BLVD, SUITE 2300 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1101 WILSON BLVD, SUITE 2300 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-56595 | Film No.: 161421336
SIC: 2834 Pharmaceutical Preparations